Evidence map›Paper›PMID 23233725›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties.

Radames J B Cordero, Bruno Pontes, Susana Frases, Antonio S Nakouzi, Leonardo Nimrichter, Marcio L Rodrigues, Nathan B Viana, Arturo Casadevall

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. The Role of Nutritional Environment inInfectious disease reports · 2025
    Article
  3. Neutron Scattering Analysis ofBiomacromolecules · 2024
    Article
  4. Methods of Cryptococcal Polysaccharide Analysis Using ELISA.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  5. Neutron Scattering Analysis ofbioRxiv : the preprint server for biology · 2023
    Article
  6. Article
  7. Ultrastructural Study ofFrontiers in microbiology · 2021
    Article
  8. Article
  9. The mechanical properties of microbial surfaces and biofilms.Cell surface (Amsterdam, Netherlands) · 2019
    Article
  10. The capsule ofVirulence · 2019
    Review
  11. ImagingBio-protocol · 2019
    Article
  12. Bacterial ABNature communications · 2019
    Article
  13. The Buoyancy ofmSphere · 2018
    Article
  14. Review
  15. Article
  16. Article
  17. The status of cryptococcosis in Latin America.Memorias do Instituto Oswaldo Cruz · 2018
    Review
  18. Review
  19. Review
  20. Antibodies and tuberculosis.Tuberculosis (Edinburgh, Scotland) · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Radames J B CorderoDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Bruno Pontes
Susana Frases
Antonio S Nakouzi
Leonardo Nimrichter
Marcio L Rodrigues
Nathan B Viana
Arturo Casadevall

Funding

Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
TRAINING PROGRAM IN CELLULAR &MOLEC. BIOLOGY &GENETICST32GM007491 · NIGMS · YESHIVA UNIVERSITY · PI QUERY, CHARLES C · 1985 to 2021
$17.0M
Synergy of Host Defense Mechanisms in the LungR01HL059842 · NHLBI · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2023
$7.4M
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONSR01AI033774 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1994 to 2014
$5.6M
Molecular Characterization of C. neoformans AntibodiesR37AI033142 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CASADEVALL, ARTURO · 2007 to 2016
$3.9M
MOLECULAR PATHOGENESIS OF INFECTIOUS DISEASEST32AI007506 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2012
$3.7M
MOLECULAR CHARACTERIZATION OF C NEOFORMANS ANTIBODIESR01AI033142 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1994 to 2006
$1.7M
NHLBI NIH HHS HL059842NHLBI NIH HHS R01 HL059842NIAID NIH HHS AI033142NIAID NIH HHS AI033774NIAID NIH HHS AI51519NIAID NIH HHS P30 AI051519NIAID NIH HHS R01 AI033142NIAID NIH HHS R01 AI033774NIAID NIH HHS R37 AI033142NIAID NIH HHS T32 AI007506NIGMS NIH HHS GM007491NIGMS NIH HHS T32 GM007491
6 · The paper itself

Abstract

Abs to microbial capsules are critical for host defense against encapsulated pathogens, but very little is known about the effects of Ab binding on the capsule, apart from producing qualitative capsular reactions ("quellung" effects). A problem in studying Ab-capsule interactions is the lack of experimental methodology, given that capsules are fragile, highly hydrated structures. In this study, we pioneered the use of optical tweezers microscopy to study Ab-capsule interactions. Binding of protective mAbs to the capsule of the fungal pathogen Cryptococcus neoformans impaired yeast budding by trapping newly emerging buds inside the parental capsule. This effect is due to profound mAb-mediated changes in capsular mechanical properties, demonstrated by a concentration-dependent increase in capsule stiffness. This increase involved mAb-mediated cross-linking of capsular polysaccharide molecules. These results provide new insights into Ab-mediated immunity, while suggesting a new nonclassical mechanism of Ab function, which may apply to other encapsulated pathogens. Our findings add to the growing body of evidence that Abs have direct antimicrobial functions independent of other components of the immune system.

Indexed as

Binding Sites, AntibodyStress, MechanicalAntibodies, FungalAntigens, FungalCell DivisionCryptococcosisCryptococcus neoformansFungal CapsulesHydrodynamicsOptical TweezersPolysaccharidesAntibodies, FungalAntigens, FungalglucuronoxylomannanPolysaccharides

Identifiers

PMID23233725
PMCPMC3529781

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.